TUESDAY, Nov. 2, 2021 (HealthDay News) — Mike Smith is beating the odds. Diagnosed with stage 4 lung cancer back in 2016, the 56-year-old South Carolina resident says there are a lot of reasons to be optimistic as the “narrative of lung cancer changes from being a horrific, terminal diseaseContinue Reading
TUESDAY, Nov. 2, 2021 (HealthDay News) — Nearly one-third of older U.S. adults visit at least five different doctors each year — reflecting the growing role of specialists in Americans’ health care, a new study finds. Over the past 20 years, Americans on Medicare have been increasingly seeing specialists, researchersContinue Reading
MONDAY, Nov. 1, 2021 (HealthDay News) — If you have a pet, you know that the excited wag of your dog’s tail or the satisfied purr of your cat curling up on your lap can be a mood booster. But what if that pet is a robot? And what ifContinue Reading
THURSDAY, Oct. 28, 2021 (HealthDay News) — A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2Continue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Do you like your burgers well done with a side of plastic? Probably not. But a new study suggests that fast food often comes with a sizable helping of plastic-softening chemicals that could potentially lead to hormone disruption, infertility and learning disabilities. AtContinue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows. Researchers found that the shorter regimen — given over five weeks, instead of seven — did not raise patients’ odds of lasting side effects.Continue Reading
TUESDAY, Oct. 26, 2021 (HealthDay News) — High-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies, a preliminary study suggests. The study involved patients whose lung cancer was considered “oligoprogressive.” That means the cancer had spread to otherContinue Reading
MONDAY, Oct. 25, 2021 (HealthDay News) — Smokers who kick the habit before age 45 can nearly eliminate their excess risk of dying from lung or other cancers, a new study estimates. It’s well-established that after smokers quit, their risk of tobacco-related cancers drops substantially over time. Researchers said theContinue Reading
THURSDAY, Oct. 21, 2021 (HealthDay News) — Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics. Researchers found that the tactic wasContinue Reading
THURSDAY, Oct. 21, 2021 (HealthDay News) — Nine of 10 patients with so-called “bubble boy” immune disease who received gene therapy about a decade ago are still disease-free, researchers report. The gene therapy was developed at the University of California, Los Angeles (UCLA), to treat the rare and deadly immuneContinue Reading